Scientists study dementia proteins
Scientists are to launch a major study of little-known proteins they believe are a contributing factor to diseases such as dementia and multiple sclerosis.
The team of biologists at the University of Portsmouth have been awarded £600,000 to research the impact on the ageing of the brain and cognitive decline.
The study will focus on a protein known as Kir4.1 which is a key element in controlling special cells in the brain and spinal cord which form myelin, a substance which insulates the brain's wiring.
They discovered that the protein is critical in ensuring these cells, known as oligodendrocytes, function well.
The researchers already know that myelin acts as the insulating layer around nerve cells and is essential for rapid conduction of information and when it is damaged this interferes with messages between the brain and other parts of the body.
They are also researching another protein called Gas6 which they have discovered can stimulate oligodendrocyte production and survival.
The team's combined research will focus on signals in the brain which stimulate the growth and regeneration of oligodendrocytes and myelin.
Professor Arthur Butt, from the School of Pharmacy and Biomedical Sciences, said: "These cells in the brain are generated at birth and during the first years of development.
"But they continue to be generated in the adult brain and are important for replacing cells lost during the normal ageing process.
"We think that the brain slows down its production of these cells as it ages and this decreases the rate at which the brain repairs its white matter - important for cognitive function.
"The area of the brain known as the hippocampus, important for storing memory, is also affected.
"Through investigating the signals used by the brain to control these functions we hope to gain further insight into the ageing brain and better understand diseases such as Alzheimer's and dementia."
The research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Multiple Sclerosis (MS) Society, will start later this year and take three years to complete.
The scientists hope the results could be used to develop experimental treatments for diseases of the brain and MS, and also contribute to future diagnostic tools for clinicians to predict Alzheimer's and dementia.
- 1 Autistic adults could take pure MDMA to 'reduce social anxiety'
- 2 Natalie Portman tells Harvard graduates: 'Accept your lack of knowledge'
- 3 Before you complain about your GP, this is what you need to know about actually doing the job
- 4 Father of 12 accused of raping, beating, starving and abusing his own children in US 'cult'
- 5 Charlie Charlie Challenge explained: not a Mexican demon being summoned — it's gravity
People are criticising Fifa World Cup sponsors with corrupt corporate logos
Natalie Portman tells Harvard graduates: 'Accept your lack of knowledge'
University league tables: Best universities for teaching standards rank Oxford, Cambridge and Coventry among top 20
Fifa corruption live: Uefa to consider pulling teams from Fifa tournaments if Blatter stays
Skull found in Spain could be the world's first-ever murder victim
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
The day that Britain resigned as a global power
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
Australian man punched in the face for defending Muslim women from abuse on train
A nation of inequality: How the UK is failing to feed its most vulnerable people
EU referendum: David Cameron to deny EU migrants and under-18s the chance to vote
Negotiable: Recruitment Genius: One of the South East's fastest growing full s...
£35-40k (DOE) + Benefits: Guru Careers: We are seeking a Marketing Communicati...
£30000 - £32000 per annum: Recruitment Genius: Estimating, preparation of tech...
£14000 - £17000 per annum: Recruitment Genius: You will work as part of a smal...